FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Pancreatic Ductal
  • Induction Chemotherapy
  • Pancreatic Neoplasms

abstract

  • Nearly one third of the patients who had been initially identified as having stage 3 pancreatic carcinoma and had been treated with FOLFIRINOX responded radiographically and underwent tumor resection.

publication date

  • October 15, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4849545

Digital Object Identifier (DOI)

  • 10.1245/s10434-015-4647-4

PubMed ID

  • 26065868

Additional Document Info

start page

  • 3512

end page

  • 21

volume

  • 22

number

  • 11